Genprex, Inc. Made Big Gain

Mon, Oct 28, 2024 at 07:35 PM

Genprex, Inc. (GNPX:NASDAQ) rocketted at $2.74, representing a gain of 38.4%. The stock got featured on our News Catalysts scanner on Mon, Oct 28, 2024 at 11:04 AM in the 'PATNERSHIP' category. From Mon, Oct 14, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days

The stock spiked on Tue, Oct 22, 2024 at $3.97 with a volume of 190M+.

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Top 10 Gainers:

Smart for Life Inc. (SMFL:NASDAQ), 172.09%
Hanryu Holdings, Inc. (HRYU:NASDAQ), 125.09%
Monte Rosa Therapeutics Inc. (GLUE:NASDAQ), 93.87%
Greenlane Holdings, Inc. (GNLN:NASDAQ), 91.92%
Movella Holdings Inc Com (MVLA:NASDAQ), 87.5%
Porch Group Inc. (PRCH:NASDAQ), 70.31%
Autonomix Medical Inc. (AMIX:NASDAQ), 60.57%
Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 39.82%
Schmitt Industries, Inc. (SMIT:NASDAQ), 39.07%
Genprex, Inc. (GNPX:NASDAQ), 38.38%